• Sign up to our Free Newsletter
  • Contact Us
Microbiome Times Magazine
  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Finance

Finance

Management Changes at BioGaia

May 24, 2018 Microbiome Times

Axel Sjöblad was appointed as Managing Director effective March 1, 2016 and has successfully focused on further expanding BioGaias sales capabilities. ”I am proud of the progress that has taken place at the company during […]

Finance

Scioto Biosciences Closes $1.8M in Series A Financing

May 21, 2018 Microbiome Times

Scioto Biosciences, a preclinical stage company developing innovative therapies to transform the delivery of microbiome therapeutics, today announced it has closed on $1.8M in Series A financing to support the launch of its new microbiome […]

Finance

Synlogic Reports First Quarter 2018 Financial Results and Provides Business Update

May 16, 2018 Microbiome Times

  Corporate Leadership Transition: On May 10, 2018, Synlogic announced a CEO transition; Chief Medical Officer, Aoife Brennan, M.B., B.Ch., was appointed to serve as Interim President and Chief Executive Officer as successor to Jose-Carlos […]

Finance

Thryve Secures $1.4 Million Funding to Expand Personalized Probiotics and Individual Microbiome Testing

May 16, 2018 Microbiome Times

Thryve, providers of high quality microbiotics and microbiome testing, announced today it has secured $1.4 million in funding. Participating investment firms include PivotNorth Capital, Unilever Ventures, Darling Ventures, Candela Paramount, Abstract Ventures and Joyance Partners. […]

Finance

Synlogic Announces Leadership Change

May 11, 2018 Microbiome Times

Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company applying synthetic biology to probiotics to develop novel, living medicines, today announced that Aoife Brennan, M.B., B.Ch., has accepted the position of Interim President and Chief Executive […]

Finance

Evelo Biosciences Announces Pricing of Initial Public Offering

May 10, 2018 Microbiome Times

Evelo Biosciences, Inc. (Nasdaq:EVLO) (“Evelo”) today announced the pricing of its initial public offering of 5,312,500 shares of common stock at a public offering price of $16.00 per share, before underwriting discounts and commissions. In […]

Finance

Lodo Therapeutics Corporation Forms Multi-Target Strategic Collaboration with Genentech

May 9, 2018 Microbiome Times

Lodo Therapeutics Corporation, a drug discovery and development company focused on identifying and producing unique, bioactive natural products directly from the microbial DNA sequence information contained in soil, today announced that it has formed a […]

Finance

Adare Pharmaceuticals Announces Changes to Executive Leadership Team; Supports Next Phase of Growth

May 9, 2018 Microbiome Times

Adare Pharmaceuticals, Inc., today announced changes to its Leadership Team to support the next phase of its growth strategy. Since its creation in 2015, the Company has been committed to becoming a global specialty pharmaceutical […]

Finance

UAS Laboratories Expands Capabilities With New Fermentation Facility

May 6, 2018 Microbiome Times

UAS Laboratories LLC (Wausau, Wisconsin, USA), is celebrating a significant milestone with the opening of their new fermentation facility, located in Madison, Wisconsin, USA. This expansion is the result of a 60-million-dollar investment made to […]

Finance

Azitra Secures $2.15 Million Convertible Debt Financing Led Jointly by Bios Partners and Connecticut Innovations

May 2, 2018 Microbiome Times

Azitra Inc. today announced that it has secured $2.15 million in convertible debt financing to support advancement of the company’s pipeline of dermatology and skin care products. The financing was led by new investor Connecticut […]

Finance

Eagle Genomics Announces Senior Leadership Changes

May 2, 2018 Microbiome Times

Eagle Genomics has appointed Executive Chairman Anthony Finbow to the post of Chief Executive, with founder Abel Ureta-Vidal moving to become Chief Product Officer. The change in management structure marks a new phase for Eagle […]

Posts navigation

« 1 … 24 25 26 27 »

Sign Up to Free Newsletter

The Microbiome Drug Database

Editor’s Choice

  • Using a novel computational approach, researchers confirm microbial diversity is wilder than ever.
    October 30, 2023
  • Pharmacomicrobiomics: The universe of microbiome-drug interactions
    October 26, 2023
  • New standards in sensitivity and accuracy for microbiome research
    September 20, 2023
  • Integrating Microbiome and Dietary Data: Microbiome Data Congress 2023
    August 22, 2023
  • Distinguishing Strains in Microbiome Samples: Considerations and Challenges
    July 19, 2023
sign up

Sign up to the Microbiome Times newsletter